이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Shanghai Haohai Biological Technology 대차 대조표 상태
재무 상태 기준 확인 5/6
Shanghai Haohai Biological Technology 의 총 주주 지분은 CN¥6.1B 이고 총 부채는 CN¥390.2M, 이는 부채 대 자기자본 비율을 6.4% 로 가져옵니다. 총자산과 총부채는 각각 CN¥7.2B 및 CN¥1.1B 입니다. Shanghai Haohai Biological Technology 의 EBIT는 CN¥407.0M 이며 이자보상배율은 -6 입니다. CN¥2.7B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
6.4%
부채 비율
CN¥390.21m
부채
| 이자 보상 비율 | -6x |
| 현금 | CN¥2.73b |
| 주식 | CN¥6.12b |
| 총 부채 | CN¥1.07b |
| 총 자산 | CN¥7.19b |
최근 재무 상태 업데이트
Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17
Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 30Recent updates
Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All
May 22Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?
Feb 12Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 30Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price
May 08Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Apr 19Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Mar 04Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 03Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?
Jan 10Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Oct 08Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly
Jul 07Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%
May 27These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Apr 04Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%
Mar 16Can Mixed Fundamentals Have A Negative Impact on Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Current Share Price Momentum?
Feb 23What Type Of Shareholders Own The Most Number of Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Shares?
Feb 05
Does Shanghai Haohai Biological Technology's (HKG:6826) Statutory Profit Adequately Reflect Its Underlying Profit?
Jan 21Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Should Think About This Before Buying It For Its Dividend
Jan 06재무 상태 분석
단기부채: 6826 의 단기 자산 ( CN¥3.7B )이 단기 부채( CN¥689.8M ).
장기 부채: 6826 의 단기 자산( CN¥3.7B )이 장기 부채( CN¥381.0M ).
부채 대 자본 내역 및 분석
부채 수준: 6826 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: 6826 의 부채 대 자기자본 비율은 지난 5년간 1% 에서 6.4% 로 증가했습니다.
부채 범위: 6826 의 부채는 영업 현금 흐름 ( 161.6% )에 의해 잘 충당되었습니다.
이자 보장: 6826 지불하는 것보다 더 많은 이자를 벌기 때문에 이자 지불 보장은 문제가 되지 않습니다.